Second generation model for prednisolone pharmacodynamics in the rat
- PMID: 2571711
- DOI: 10.1007/BF01059029
Second generation model for prednisolone pharmacodynamics in the rat
Abstract
An improved model describing receptor/gene-mediated pharmacodynamics of prednisolone is presented which consists of seven differential equations. Data for plasma prednisolone concentrations, free hepatic glucocorticoid receptors, and hepatic tyrosine aminotransferase activity (TAT) following low (5 mg/kg) and high (50 mg/kg) doses of prednisolone are used to quantitate the kinetics and dynamics of this synthetic steroid in the rat. In contrast to the earlier model, the newer model provides for a coupling and simultaneous fitting of receptor and TAT data and is able to describe the recycling of receptors between cytosol and nucleus and the return of cytosolic receptors to baseline following glucocorticoid elimination. A numerical technique to determine the efficiency of TAT induction based on area under the curve calculations is presented, which supports the hypothesis that nonlinear dose-response effects are due to dose and time-dependent receptor depletion in the cytosol. Simulations are presented to examine the major determinants of corticosteroid effects and to compare the effects of single- and multiple-dose regimens in maximizing drug effects.
Similar articles
-
Receptor-mediated methylprednisolone pharmacodynamics in rats: steroid-induced receptor down-regulation.J Pharmacokinet Biopharm. 1992 Aug;20(4):333-55. doi: 10.1007/BF01062462. J Pharmacokinet Biopharm. 1992. PMID: 1362219
-
Receptor-mediated prednisolone pharmacodynamics in rats: model verification using a dose-sparing regimen.J Pharmacokinet Biopharm. 1990 Jun;18(3):189-208. doi: 10.1007/BF01062199. J Pharmacokinet Biopharm. 1990. PMID: 1974305
-
Receptor-mediated pharmacodynamics of prednisolone in the rat.J Pharmacokinet Biopharm. 1986 Oct;14(5):469-93. doi: 10.1007/BF01059656. J Pharmacokinet Biopharm. 1986. PMID: 2879901
-
Pharmacokinetics and receptor-mediated pharmacodynamics of corticosteroids.Toxicology. 1995 Sep 1;102(1-2):189-96. doi: 10.1016/0300-483x(95)03047-j. Toxicology. 1995. PMID: 7482553 Review.
-
Vitamin B6 and glucocorticoid action.Endocr Rev. 1986 May;7(2):140-8. doi: 10.1210/edrv-7-2-140. Endocr Rev. 1986. PMID: 2873032 Review. No abstract available.
Cited by
-
Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.J Pharmacokinet Biopharm. 1998 Jun;26(3):289-317. doi: 10.1023/a:1023233409550. J Pharmacokinet Biopharm. 1998. PMID: 10098101
-
Two-compartment basophil cell trafficking model for methylprednisolone pharmacodynamics.J Pharmacokinet Biopharm. 1991 Oct;19(5):521-36. doi: 10.1007/BF01062961. J Pharmacokinet Biopharm. 1991. PMID: 1783990
-
Receptor-mediated methylprednisolone pharmacodynamics in rats: steroid-induced receptor down-regulation.J Pharmacokinet Biopharm. 1992 Aug;20(4):333-55. doi: 10.1007/BF01062462. J Pharmacokinet Biopharm. 1992. PMID: 1362219
-
Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.Pharmacol Rev. 2020 Apr;72(2):414-438. doi: 10.1124/pr.119.018101. Pharmacol Rev. 2020. PMID: 32123034 Free PMC article. Review.
-
Third-generation model for corticosteroid pharmacodynamics: roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver.J Pharmacokinet Biopharm. 1995 Apr;23(2):163-81. doi: 10.1007/BF02354270. J Pharmacokinet Biopharm. 1995. PMID: 8719235